BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6241663)

  • 1. New vistas on bone scintigraphy.
    Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
    Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
    Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
    [No Abstract]   [Full Text] [Related]  

  • 3. Reaction of 99mTc-diphosphonate with N-donor ligands.
    Johannsen B
    Int J Appl Radiat Isot; 1982 Jun; 33(6):429-32. PubMed ID: 6286510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantification in bone scintigraphy with Tc-99m-phosphonates: determinants and data points].
    Büll U; Reinartz P
    Nuklearmedizin; 2000 Aug; 39(5):N69-71. PubMed ID: 10984892
    [No Abstract]   [Full Text] [Related]  

  • 5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone scan as a tumour marker in prostatic carcinoma.
    Chisholm GD; Stone AR; Beynon LL; Merrick MV
    Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
    Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
    J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
    [No Abstract]   [Full Text] [Related]  

  • 9. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do we want from a bone-scanning agent?
    Fogelman I; Bessent RG
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic necrosis of the knee: bone scintigraphy.
    Burt RW; Matthews TJ
    AJR Am J Roentgenol; 1982 Mar; 138(3):571-3. PubMed ID: 6461229
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities.
    Kirchner PT; Simon MA
    J Bone Joint Surg Am; 1984 Mar; 66(3):319-27. PubMed ID: 6230363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruptured abdominal aortic aneurysm identified incidental to bone scintigraphy.
    Moreno AJ; Brown JM; Spicer MJ; Brown TJ
    Eur J Nucl Med; 1983; 8(12):546-8. PubMed ID: 6230233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
    Watt I; Hill P
    Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Giant cell tumor of the bone (author's transl)].
    Hikita C; Yamagishi Y; Okuyama A
    Rinsho Hoshasen; 1981 Aug; 26(8):907-8. PubMed ID: 6457188
    [No Abstract]   [Full Text] [Related]  

  • 19. Skeletal scintigraphy with technetium diphosphonate in multiple myeloma--a comparison with skeletal x-ray.
    Lindström E; Lindström FD
    Acta Med Scand; 1980; 208(4):289-91. PubMed ID: 6449830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.
    Simon MA; Kirchner PT
    J Bone Joint Surg Am; 1980 Jul; 62(5):758-64. PubMed ID: 6446566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.